Serial CTRS (CT Response Score) improves prediction of overall survival compared to RECIST 1.1 and Tumor Volume Change in advanced NSCLC CHICAGO--(BUSINESS WIRE)--Onc.AI, a digital health company ...

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...

The hematology/oncology workforce endorses the incorporation of AI into medical education, according to findings presented at ...

BeOne Medicines Ltd. (NASDAQ:ONC) has unveiled new data from the pivotal Phase 3 SEQUOIA trial at the 2025 ASCO Annual ...

A new phase: Since before he became secretary, Kennedy has talked about using AI in myriad ways, including to provide ...